BMY-21502

BMY-21502 is a potential cognitive enhancer that shows anti-hypoxia effects in the KCN-hypoxia model, delays the decay of hippocampal synaptic enhancement in vitro, and can be used to study Alzheimer's disease.

Product Specifications

CAS Number

123259-91-6

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

328.33

Molecular Formula

C15H19F3N4O

Notes

Research use only, not for human use.

Receptor

Antioxidant

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

DAG2016 100 µg

EBV Glycoprotein H(DI-II), gL, Gp 42 (aa 25 - 137)(Ectodomain) [His]

Ask

View Details

FNab03045 100 µg

FBXO41 antibody

Ask

View Details

124461-ML490 100 µL

CCL23 (C-C Motif Chemokine 23, CK-beta-8, CKB-8, Macrophage Inflammatory Protein 3, MIP-3, Myeloid Progenitor Inhibitory Factor 1, MPIF-1, Small-inducible Cytokine A23, MIP3, MPIF1, SCYA23) (MaxLight 490)

Ask

View Details

MBS5802433 Inquire

gamma-Secretase-IN-1

Ask

View Details